Works matching IS 21644403 AND DT 2020 AND VI 10 AND IP 5
Results: 18
Jelmyto Approved by FDA for Low-Grade Upper- Tract Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 42
- Publication type:
- Article
Pemazyre First FDA-Approved Therapy for Cholangiocarcinoma plus FGFR2 Fusion.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 41
- Publication type:
- Article
Tukysa Approved with Chemotherapy for Heavily Pretreated HER2-Positive Metastatic Breast Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 41
- Publication type:
- Article
Building the Case: Oncology Patient Navigation and Payer Engagement.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 39
- By:
- Publication type:
- Article
Launch of New Telehealth Service Addresses Urologist Shortage in Underserved Populations.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 38
- By:
- Publication type:
- Article
Video Telehealth Clinic Provides Convenient and Cost-Effective Care for Veterans with Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 36
- By:
- Publication type:
- Article
PSMA-PET Scanning Wave of the Future in Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 34
- By:
- Publication type:
- Article
International Society of Cannabis Pharmacists Plans to Hold Inaugural Meeting in 2020.
- Published in:
- 2020
- By:
- Publication type:
- Interview
Combination of NUC-1031 plus Cisplatin Shows Promise as First-Line Treatment for Advanced Biliary Tract Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 28
- By:
- Publication type:
- Article
First-in-Class Oral MK-6482 Shows Exciting Results in Clear-Cell Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 26
- By:
- Publication type:
- Article
SBRT plus Immunotherapy in Metastatic Renal-Cell Carcinoma Warrants Further Study.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 24
- By:
- Publication type:
- Article
Atezolizumab-Bevacizumab Combo Improves Survival and Quality of Life in Unresectable Liver Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 22
- By:
- Publication type:
- Article
Adding 2 Immunotherapies to Cabozantinib Extends Survival in Advanced Liver Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 20
- By:
- Publication type:
- Article
ASCO Publishes First Guideline on Use of Molecular Biomarkers in Localized Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 18
- By:
- Publication type:
- Article
NCCN Issues Guidance for Cancer Care During the COVID-19 Pandemic.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 8
- By:
- Publication type:
- Article
Coronavirus and the Cancer Patient.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 1
- By:
- Publication type:
- Article
MicroRNAs Have Promise as Biomarker in Testicular and Other Germ-Cell Tumors.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 1
- By:
- Publication type:
- Article
Wholesale Supply Channels: COVID-19 Impact on Cancer Care and Road to Recovery.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 5, p. 1
- Publication type:
- Article